Literature DB >> 15366011

Role of FGFR signaling in the morphogenesis of the Drosophila visceral musculature.

Lolitika Mandal1, Karin Dumstrei, Volker Hartenstein.   

Abstract

We report in this study that the longitudinal visceral muscle founder cells (LVMFs), a population of cells that migrate along the midgut primordium and visceral mesoderm, require the function of the Drosophila fibroblast growth factor receptor (FGFR) homolog, Heartless (Htl). Htl is expressed in LVMFs before and during their migration, and mitogen-activated protein K (MAPK) activity is present at the same stage. Embryos deficient for htl show an almost complete absence of longitudinal visceral fibers at late stages. In line with previous studies implicating FGFR signaling in morphogenetic movements, we conclude that the defect we observe in htl mutant embryos indicates a role of this signaling pathway in cell migration and/or differentiation of the LVMFs. Given that, in addition to hemocytes, LVMFs are the only cells of the Drosophila embryo that migrate over large distances, we propose that these cells represent a highly suitable system to dissect the role of signaling pathways in cell migration in Drosophila. 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15366011     DOI: 10.1002/dvdy.20088

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  12 in total

1.  HLH54F is required for the specification and migration of longitudinal gut muscle founders from the caudal mesoderm of Drosophila.

Authors:  Afshan Ismat; Christoph Schaub; Ingolf Reim; Katharina Kirchner; Dorothea Schultheis; Manfred Frasch
Journal:  Development       Date:  2010-09       Impact factor: 6.868

2.  Migrating cells control morphogenesis of substratum serving as track to promote directional movement of the collective.

Authors:  Frank Macabenta; Angelike Stathopoulos
Journal:  Development       Date:  2019-07-16       Impact factor: 6.868

3.  Comparative analysis of gene expression profiles for several migrating cell types identifies cell migration regulators.

Authors:  Young-Kyung Bae; Frank Macabenta; Heather Leigh Curtis; Angelike Stathopoulos
Journal:  Mech Dev       Date:  2017-04-18       Impact factor: 1.882

4.  Synchronous and symmetric migration of Drosophila caudal visceral mesoderm cells requires dual input by two FGF ligands.

Authors:  Snehalata Kadam; Srimoyee Ghosh; Angelike Stathopoulos
Journal:  Development       Date:  2012-01-04       Impact factor: 6.868

5.  The migrations of Drosophila muscle founders and primordial germ cells are interdependent.

Authors:  Vincent Stepanik; Leslie Dunipace; Young-Kyung Bae; Frank Macabenta; Jingjing Sun; Nathanie Trisnadi; Angelike Stathopoulos
Journal:  Development       Date:  2016-09-01       Impact factor: 6.868

6.  The FGF8-related signals Pyramus and Thisbe promote pathfinding, substrate adhesion, and survival of migrating longitudinal gut muscle founder cells.

Authors:  Ingolf Reim; Dominik Hollfelder; Afshan Ismat; Manfred Frasch
Journal:  Dev Biol       Date:  2012-05-17       Impact factor: 3.582

7.  Analysis of Thisbe and Pyramus functional domains reveals evidence for cleavage of Drosophila FGFs.

Authors:  Sarah Tulin; Angelike Stathopoulos
Journal:  BMC Dev Biol       Date:  2010-08-05       Impact factor: 1.978

Review 8.  Receptor tyrosine kinases in Drosophila development.

Authors:  Richelle Sopko; Norbert Perrimon
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-06-01       Impact factor: 10.005

9.  Spatiotemporal sensitivity of mesoderm specification to FGFR signalling in the Drosophila embryo.

Authors:  V Yadav; N Tolwinski; T E Saunders
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

Review 10.  The role of FGF signaling in guiding coordinate movement of cell groups: guidance cue and cell adhesion regulator?

Authors:  Young-Kyung Bae; Nathanie Trisnadi; Snehalata Kadam; Angelike Stathopoulos
Journal:  Cell Adh Migr       Date:  2012-09-01       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.